The muscular dystrophies, Lancet, vol.359, pp.687-95, 2002. ,
Effect of genetic background on the dystrophic phenotype in mdx mice, Hum Mol Genet, vol.25, pp.130-175, 2016. ,
Dystrophindeficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma, FASEB J, vol.21, pp.2195-204, 2007. ,
Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy, PLoS ONE, vol.9, p.110371, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01190124
Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents, Neuromuscul Disord, vol.27, pp.635-680, 2017. ,
Immune-mediated pathology in Duchenne muscular dystrophy, Sci Transl Med, vol.7, pp.299-294, 2015. ,
Duchenne muscular dystrophy and steroids: pharmacologic treatment in the absence of effective gene therapy, J Pediatr Orthop, vol.25, pp.554-560, 2005. ,
Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology, Neurology, vol.86, pp.465-72, 2016. ,
Dystrophin immunity in Duchenne's muscular dystrophy, N Engl J Med, vol.363, pp.1429-1466, 2010. ,
Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy, J Immunol, vol.153, pp.4798-805, 1994. ,
Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect, Hum Gene Ther, vol.24, pp.797-806, 2013. ,
A special population of regulatory T cells potentiates muscle repair, Cell, vol.155, pp.1282-95, 2013. ,
Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy, Sci Transl Med, vol.6, pp.258-142, 2014. ,
Ex vivo expanded human non-cytotoxic CD8(+)CD45RC(low/-) tregs efficiently delay skin graft rejection and GVHD in humanized mice, Front Immunol, vol.8, 2014. ,
Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells, JCI Insight, vol.2, p.90088, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01833115
Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases, FASEB J, vol.27, pp.703-714, 2013. ,
Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells, PLoS ONE, vol.10, p.119686, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02149009
Prednisolone-induced changes in dystrophic skeletal muscle, FASEB J, vol.19, pp.834-840, 2005. ,
Corticosteroids for the treatment of Duchenne muscular dystrophy, Cochrane Database Syst Rev, vol.5, p.3725, 2016. ,
Use of Grip Strength Meter to Assess the Limb Strength of mdx Mice, SOP, vol.22001, 2008. ,
Soluble milk protein supplementation with moderate physical activity improves locomotion function in aging rats, PLoS ONE, vol.11, p.167707, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01831752
Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy, J Neurochem, vol.136, pp.351-62, 2016. ,
Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis, FASEB J, vol.18, pp.676-82, 2004. ,
Functional and morphological improvement of Dystrophic muscle by interleukin 6 receptor blockade, EBioMedicine, vol.2, pp.285-93, 2015. ,
Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice, Fibrogenesis Tissue Repair, vol.7, p.1, 2014. ,
Sulforaphane attenuates muscle inflammation in Dystrophin-deficient mdx mice via NF-E2-related factor 2 (Nrf2)-mediated Inhibition of NF-kappaB signaling pathway, J Biol Chem, vol.290, pp.17784-95, 2015. ,
Effect of the IL-1 receptor antagonist kineret(R) on disease phenotype in mdx mice, PLoS ONE, vol.11, 2016. ,
Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention, PM R, vol.1, pp.755-68, 2009. ,
Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts, J Clin Invest, vol.125, pp.2677-89, 2015. ,
Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy, J Neuroimmunol, vol.175, pp.77-86, 2006. ,
Advances on CD8+ Tregs and their potential in transplantation, Transplantation, vol.102, pp.1467-78, 2018. ,
Antigen-and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice, Cell Metab, vol.21, pp.543-57, 2015. ,
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects, EMBO Mol Med, vol.5, pp.1569-85, 2013. ,
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug, Pharmacol Res, vol.136, pp.140-50, 2018. ,
An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells, J Exp Med, vol.201, pp.1293-305, 2005. ,
Prevention and reversal of renal allograft rejection by antibody against CD45RB, Nature, vol.380, pp.717-737, 1996. ,
Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle, Clin Immunol, vol.98, pp.235-278, 2001. ,
Immunological characterization of a rat model of Duchenne's disease and demonstration of improved muscle strength after anti-CD45RC antibody treatment, bioRxiv, p.407023, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02509540